InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. The company's C5a is an inflammatory mediator to treat variety of autoimmune and other inflam...
Leadership
Niels C. Riedemann M.D., Ph.D.Founder
Co-Founder, CEO & Executive Director
Renfeng Guo M.D.Founder
Co-Founder, Chief Scientific Officer & Executive Director
Thomas Taapken Ph.D.
Chief Financial Officer
Derval O'Carroll
Senior VP and Global Head of Regulatory Affairs & Compliance
